Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 1,650 | 0 |
| Other current assets | 0 | 0 | 50 | 0 |
| TOTAL | $0 | $0 | $1,700 | $0 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | 460 | N/A |
| Other Non-Current Assets | 0 | 0 | 60 | 0 |
| TOTAL | $N/A | $N/A | $520 | $N/A |
| Total Assets | $0 | $0 | $2,120 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 390 | 0 |
| Accrued Expenses | 0 | 0 | 260 | 0 |
| TOTAL | $0 | $0 | $1,050 | $0 |
| Non-Current Liabilities | ||||
| Long Term Debt | 0 | 0 | 430 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 11,740 | 0 |
| TOTAL | $N/A | $N/A | $12,170 | $N/A |
| Total Liabilities | $0 | $0 | $13,240 | $0 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 7 | 0 |
| Retained earnings | 0 | 0 | -11,120 | 0 |
| Other shareholders' equity | 0 | 0 | 3 | 0 |
| TOTAL | $0 | $0 | $-11,110 | $0 |
| Total Liabilities And Equity | $0 | $0 | $2,130 | $0 |